ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Metagenomi Inc

Metagenomi Inc (MGX)

2.05
0.16
( 8.47% )
更新日時: 00:54:37

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
2.05
買値
2.04
売値
2.05
出来高
375,770
1.9025 日の範囲 2.095
1.61 52 週間の範囲 12.74
時価総額
前日終値
1.89
始値
1.93
最終取引時間
00:54:37
財務取引量
US$ 761,879
VWAP
2.0275
平均取引量 (3 か月)
345,625
発行済株式数
37,423,917
配当利回り
-
PER
-1.12
1 株当たり利益 (EPS)
-1.82
歳入
44.76M
純利益
-68.26M

Metagenomi Inc について

At Metageno-mi, we are cre-at-ing poten-tial-ly cura-tive ther-a-peu-tics using our metage--nomics-pow-ered genome edit-ing toolbox.We believe tools with capa-bil-i-ties that go beyond the cur-rent tech-nol-o-gy land-scape will be required in order to reach the full ther-a-peu-tic poten-tial of geno... At Metageno-mi, we are cre-at-ing poten-tial-ly cura-tive ther-a-peu-tics using our metage--nomics-pow-ered genome edit-ing toolbox.We believe tools with capa-bil-i-ties that go beyond the cur-rent tech-nol-o-gy land-scape will be required in order to reach the full ther-a-peu-tic poten-tial of genome edit-ing. By har-ness-ing the pow-er of metage-nomics, the study of genomes recov-ered from uncul-ti-vat-ed organ-isms in the nat-ur-al envi-ron-ment, we are dis-cov-er-ing and devel-op-ing a suite of nov-el genome edit-ing tools with the poten-tial to make any desired ther-a-peu-tic gene edit, any-where in the human genome. 詳細を表示

セクター
Biological Pds,ex Diagnstics
業界
Biological Pds,ex Diagnstics
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Metagenomi Inc is listed in the Biological Pds,ex Diagnstics sector of the ナスダック市場 with ticker MGX. The last closing price for Metagenomi was US$1.89. Over the last year, Metagenomi shares have traded in a share price range of US$ 1.61 to US$ 12.74.

Metagenomi currently has 37,423,917 shares in issue. The market capitalisation of Metagenomi is US$70.73 million. Metagenomi has a price to earnings ratio (PE ratio) of -1.12.

MGX 最新ニュース

The Gross Law Firm Notifies Metagenomi, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MGX

The Gross Law Firm Notifies Metagenomi, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MGX PR Newswire NEW YORK, Nov. 22, 2024 NEW YORK, Nov. 22, 2024 /PRNewswire/ -- The Gross...

November 25, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MGX

November 25, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MGX PR Newswire NEW YORK, Nov. 21, 2024 NEW YORK, Nov. 21, 2024 /PRNewswire/ -- The Gross Law Firm issues...

Investors who lost money on Metagenomi, Inc.(MGX) should contact The Gross Law Firm about pending Class Action - MGX

Investors who lost money on Metagenomi, Inc.(MGX) should contact The Gross Law Firm about pending Class Action - MGX PR Newswire NEW YORK, Nov. 18, 2024 NEW YORK, Nov. 18, 2024 /PRNewswire/...

Class Action Filed Against Metagenomi, Inc. (MGX) Seeking Recovery for Investors - Contact The Gross Law Firm

Class Action Filed Against Metagenomi, Inc. (MGX) Seeking Recovery for Investors - Contact The Gross Law Firm PR Newswire NEW YORK, Nov. 14, 2024 NEW YORK, Nov. 14, 2024 /PRNewswire/ -- The Gross...

Metagenomi Reports Business Updates and Third Quarter 2024 Financial Results

Initiating IND-enabling activities for MGX-001 development candidate (DC) in hemophilia A; Achieved durable Factor VIII activity levels over twelve months in nonhuman primate (NHP) study On track...

Shareholders that lost money on Metagenomi, Inc.(MGX) should contact The Gross Law Firm about pending Class Action - MGX

Shareholders that lost money on Metagenomi, Inc.(MGX) should contact The Gross Law Firm about pending Class Action - MGX PR Newswire NEW YORK, Nov. 11, 2024 NEW YORK, Nov. 11, 2024 /PRNewswire/...

Class Action Filed Against Metagenomi, Inc. (MGX) Seeking Recovery for Investors - Contact The Gross Law Firm

Class Action Filed Against Metagenomi, Inc. (MGX) Seeking Recovery for Investors - Contact The Gross Law Firm PR Newswire NEW YORK, Nov. 7, 2024 NEW YORK, Nov. 7, 2024 /PRNewswire/ -- The Gross...

Metagenomi To Present New Preclinical Hemophilia A Data at American Society of Hematology (ASH) 66th Annual Meeting

EMERYVILLE, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its...

Metagenomi, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before November 25, 2024 to Discuss Your Rights - MGX

Metagenomi, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before November 25, 2024 to Discuss Your Rights - MGX PR Newswire NEW YORK, Nov. 4, 2024 NEW YORK, Nov. 4, 2024...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.210.81081081081.852.0951.616827481.74916073CS
40.052.522.341.614672361.93241303CS
12-0.9-30.50847457632.9531.613456252.06774382CS
26-4.5-68.70229007636.556.91.612044062.47365167CS
52-8.2-8010.2512.741.611926484.9562968CS
156-8.2-8010.2512.741.611926484.9562968CS
260-8.2-8010.2512.741.611926484.9562968CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
QMCOQuantum Corporation
US$ 21.59
(136.47%)
16.44M
RGTIRigetti Computing Inc
US$ 3.045
(75.00%)
179.82M
QMMMQMMM Holdings Limited
US$ 1.14
(52.02%)
75.53M
XCURExicure Inc
US$ 27.50
(49.62%)
1.32M
OPIOffice Properties Income Trust
US$ 1.685
(48.46%)
3.66M
SAVACassava Sciences Inc
US$ 4.2201
(-84.06%)
50.19M
CMAXCareMax Inc
US$ 0.4923
(-31.63%)
1.64M
ONCTOncternal Therapeutics Inc
US$ 0.80
(-29.82%)
230.91k
NWTNNWTN Inc
US$ 1.04
(-28.77%)
282.17k
SHOTWSafety Shot Inc
US$ 0.112
(-25.33%)
800
RGTIRigetti Computing Inc
US$ 3.045
(75.00%)
179.82M
ELABElevai Labs Inc
US$ 0.0158
(-21.39%)
140.17M
CTXRCitius Pharmaceuticals Inc
US$ 0.1418
(5.98%)
110.51M
NVDANVIDIA Corporation
US$ 137.60
(-3.06%)
103.39M
SMCISuper Micro Computer Inc
US$ 38.2322
(15.33%)
78.49M